SSAA09E2 |
カタログ番号GC62236 |
SSAA09E2 は、SARS-CoV (重症急性呼吸器症候群-コロナウイルス) 複製の阻害剤であり、SARS-S と SARS-CoV の受容体であるアンジオテンシン変換酵素-2 (ACE2) との初期の相互作用をブロックすることによって作用します 。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 883944-52-3
Sample solution is provided at 25 µL, 10mM.
SSAA09E2 is an inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2) [1].
[1]. Bibi N, et al. Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19. Eur J Pharmacol. 2020;885:173496.
Average Rating: 5
(Based on Reviews and 23 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *